Synopsys, Inc. $SNPS Stake Raised by Focus Advisor Solutions LLC

Focus Advisor Solutions LLC raised its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 88.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,290 shares of the semiconductor company’s stock after purchasing an additional 3,901 shares during the quarter. Focus Advisor Solutions LLC’s holdings in Synopsys were worth $3,606,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of SNPS. BlackRock Inc. acquired a new position in shares of Synopsys during the 2nd quarter worth $7,228,099,000. Van ECK Associates Corp lifted its position in shares of Synopsys by 19.7% during the 2nd quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company’s stock worth $1,542,175,000 after buying an additional 569,687 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Synopsys by 40.7% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company’s stock valued at $1,377,174,000 after buying an additional 892,736 shares in the last quarter. Assenagon Asset Management S.A. boosted its stake in Synopsys by 11.2% in the third quarter. Assenagon Asset Management S.A. now owns 2,729,988 shares of the semiconductor company’s stock valued at $1,187,381,000 after buying an additional 274,586 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in Synopsys in the second quarter valued at about $747,400,000. Institutional investors own 85.47% of the company’s stock.

Insider Transactions at Synopsys

In other news, CEO Sassine Ghazi sold 14,604 shares of Synopsys stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the sale, the chief executive officer directly owned 76,865 shares of the company’s stock, valued at approximately $28,815,151.20. This trade represents a 15.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Aart de Geus sold 25,000 shares of Synopsys stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $441.76, for a total value of $11,044,000.00. Following the sale, the insider directly owned 120,421 shares in the company, valued at $53,197,180.96. The trade was a 17.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 117,163 shares of company stock valued at $51,366,457 over the last three months. Company insiders own 0.56% of the company’s stock.

Synopsys Stock Down 8.0%

Shares of SNPS opened at $396.55 on Friday. Synopsys, Inc. has a 52 week low of $362.55 and a 52 week high of $539.48. The stock has a market capitalization of $76.00 billion, a price-to-earnings ratio of 44.85, a PEG ratio of 1.40 and a beta of 1.18. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. The stock has a fifty day moving average of $448.46 and a 200-day moving average of $440.14.

Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. The business had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. Synopsys’s quarterly revenue was up 42.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, sell-side analysts anticipate that Synopsys, Inc. will post 11.01 earnings per share for the current fiscal year.

Synopsys announced that its board has authorized a share buyback program on Monday, October 5th that allows the company to buy back $1 billion in shares. This buyback authorization allows the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Share buyback programs are usually an indication that the company’s management believes its shares are undervalued.

Analysts Set New Price Targets

Several research analysts have commented on SNPS shares. Deutsche Bank reissued a “buy” rating and set a $640.00 target price (up from $590.00) on shares of Synopsys in a research note on Thursday, October 1st. Morgan Stanley increased their target price on shares of Synopsys from $500.00 to $574.00 and gave the stock an “overweight” rating in a report on Tuesday, October 20th. Weiss Ratings downgraded shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, September 11th. KeyCorp lifted their price target on shares of Synopsys from $600.00 to $605.00 and gave the company an “overweight” rating in a report on Thursday, October 1st. Finally, Barclays assumed coverage on shares of Synopsys in a report on Thursday. They set an “overweight” rating and a $640.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $577.71.

Get Our Latest Analysis on SNPS

More Synopsys News

These are some of the SNPS news items that stood out recently:

  • Positive Sentiment: Barclays initiated coverage with an Overweight rating and a $640 price target, citing Synopsys’ leadership in electronic design automation, AI-related R&D tailwinds and long-term free-cash-flow potential. The bullish call was accompanied by a gain in Thursday trading. Barclays starts Synopsys at Overweight
  • Positive Sentiment: Synopsys-backed Ansys is supporting an integration between Instem’s toxicology tools and its simulation platform, extending the company’s reach into packaging safety and materials-risk workflows. This could broaden use of its simulation ecosystem, though the financial impact is not specified. Synopsys broadens platform reach
  • Neutral Sentiment: Synopsys is described as having stronger forward growth and a lower forward valuation multiple than Cadence, but Cadence is credited with a stronger balance sheet and returns on capital. Synopsys vs. Cadence

About Synopsys

(Free Report)

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.